Somatostatin receptor 4

SSTR4
Identifiers
AliasesSSTR4, SS-4-R, SS4-R, SS4R, Somatostatin receptor 4
External IDsOMIM: 182454; MGI: 105372; HomoloGene: 20286; GeneCards: SSTR4; OMA:SSTR4 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

6754

20608

Ensembl

ENSG00000132671

ENSMUSG00000037014

UniProt

P31391

P49660

RefSeq (mRNA)

NM_001052

NM_009219

RefSeq (protein)

NP_001043

NP_033245

Location (UCSC)Chr 20: 23.04 – 23.04 MbChr 2: 148.24 – 148.24 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Somatostatin receptor type 4 is a protein that in humans is encoded by the SSTR4 gene.[5][6]

Function

Somatostatin acts at many sites to inhibit the release of many hormones and other secretory proteins. The biologic effects of somatostatin are probably mediated by a family of G protein-coupled receptors that are expressed in a tissue-specific manner. SSTR4 is a member of the superfamily of receptors having seven transmembrane segments and is expressed in highest levels in fetal and adult brain and lung.[6]

Ligands

Agonists
  • J-2156 [7]
  • L-803087 [8]
  • Mazisotine (LY3556050) [9]
  • NNC 26-9100 [10]

See also

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000132671Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000037014Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schüle R (May 1993). "Cloning and characterization of a fourth human somatostatin receptor". Proceedings of the National Academy of Sciences of the United States of America. 90 (9): 4196–200. Bibcode:1993PNAS...90.4196R. doi:10.1073/pnas.90.9.4196. PMC 46473. PMID 8483934.
  6. ^ a b "Entrez Gene: SSTR4 somatostatin receptor 4".
  7. ^ Engström M, Tomperi J, El-Darwish K, Ahman M, Savola JM, Wurster S. Superagonism at the human somatostatin receptor subtype 4. J Pharmacol Exp Ther. 2005 Jan;312(1):332-8. doi:10.1124/jpet.104.075531 PMID 15333679
  8. ^ Moneta D, Richichi C, Aliprandi M, Dournaud P, Dutar P, Billard JM, Carlo AS, Viollet C, Hannon JP, Fehlmann D, Nunn C, Hoyer D, Epelbaum J, Vezzani A. Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice. Eur J Neurosci. 2002 Sep;16(5):843-9. doi:10.1046/j.1460-9568.2002.02146.x PMID 12372020
  9. ^ Borbély É, Pethő G. Drug effects on neuropeptides and their receptors: Big hopes but moderate success in the treatment of chronic pain. Current Opinion in Pharmacology 2024 Aug 1;77:102474. doi:10.1016/j.coph.2024.102474 PMID 39121555
  10. ^ Sandoval KE, Farr SA, Banks WA, Crider AM, Morley JE, Witt KA. Somatostatin receptor subtype-4 agonist NNC 26-9100 decreases extracellular and intracellular Aβ1-42 trimers. Eur J Pharmacol. 2012 May 15;683(1-3):116-24. doi:10.1016/j.ejphar.2012.03.020 PMID 22449380

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.